-
Je něco špatně v tomto záznamu ?
WHO model prescribing information : drugs used in skin diseases
- Publikováno
- Geneva : WHO, 1997
- Edice
- WHO model prescribing information
- Stránkování
- 126 s. ; 20 cm
Jazyk angličtina Země Švýcarsko
Typ dokumentu publikace WHO
Knihovny.cz ISBN
92-4-140106-0
- MeSH
- bakteriální nemoci kůže MeSH
- dermatologické látky MeSH
- ekzematózní onemocnění kůže MeSH
- kožní nemoci farmakoterapie MeSH
- papuloskvamózní nemoci kůže MeSH
- parazitární onemocnění kůže MeSH
- vezikulobulózní nemoci kůže MeSH
- virová kožní onemocnění MeSH
- Konspekt
- Lékařské vědy. Lékařství
- NLK Obory
- farmacie a farmakologie
- dermatovenerologie
- dermatovenerologie
- farmakoterapie
- farmakoterapie
- NLK Publikační typ
- publikace WHO
Provides model prescribing information for essential drugs used in the treatment of skin diseases. Emphasis is placed on skin diseases commonly found in developing countries, since rural communities in these areas continue to experience considerable disability, disfigurement, and distress caused by curable or controllable diseases. Some rare but life-threatening disorders, such as pemphigus, are also briefly discussed. The aim is to provide reliable guidelines for treating these diseases - safely, effectively, and at the lowest possible cost - in the community and knowing when patients must be referred for highly specialized care. Though emphasis is placed on management using drugs in the WHO Model List of Essential Drugs, the book also discusses prevention through improvements in hygiene, nutrition, housing, sanitation, and other environmental factors. The book has two parts. The first briefly profiles common skin diseases, moving from parasitic infections, through fungal, bacterial, and viral infections, to papulosquamous diseases, pigmentary disorders, and malignant melanoma.Conditions common in children, acne vulgaris, cutaneous reactions to drugs, and urticaria are also covered. Each disease or group of diseases is introduced with facts about its prevalence, manifestations, and causes, followed by advice on prevention and management, including recommended drugs and dosage schedules. The second part presents model prescribing information for essential drugs used in the treatment of skin diseases. Each drug is described according to a common format which covers clinical indications, dosage and administration, contraindications and precautions, use in pregnancy, adverse effects, drug interactions, and proper storage.
Index: s. 119-126
| Vlastník | Detaily | Služby | |||||
|---|---|---|---|---|---|---|---|
| NLK | NLK Signatura K 69171 [1] | ||||||
Nahrávání dat ...
|
|||||||
| NLK-OVI MZ ČR | NLK-OVI MZ ČR Signatura W 217 [1] | ||||||
Nahrávání dat ...
|
|||||||
| SÚKL | SÚKL Signatura SÚKL 3859 [1] | ||||||
Nahrávání dat ...
|
|||||||
- 000
- 01197nam 2200373 a 4500
- 001
- MED00037628
- 003
- CZ-PrNML
- 005
- 20141219125330.0
- 008
- 980105s1997 sz eng||
- 009
- BK
- 020 __
- $a 92-4-140106-0 $q (brož.)
- 040 __
- $a ABA008 $b cze $d ABE015 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz $c CH
- 072 _7
- $x Lékařské vědy. Lékařství $a 61 $2 konspekt $7 sk136310
- 080 __
- $a 615 $2 h
- 080 __
- $a 616.5 $2 h
- 080 __
- $a 616.97 $2 h
- 080 __
- $a 615.2 $2 h
- 080 __
- $a 611.77 $2 h
- 245 00
- $a WHO model prescribing information : $b drugs used in skin diseases
- 260 __
- $a Geneva : $b WHO, $c 1997
- 300 __
- $a 126 s. ; $c 20 cm
- 490 1_
- $a WHO model prescribing information
- 504 __
- $a Index: s. 119-126
- 650 07
- $a kožní nemoci $x farmakoterapie $2 czmesh $7 D012871
- 650 07
- $a dermatologické látky $2 czmesh $7 D003879
- 650 07
- $a farmacie a farmakologie $2 mednas $7 nlk20040147252
- 650 07
- $a dermatovenerologie $2 mednas $7 nlk20040147211
- 650 07
- $a dermatovenerologie $2 mednas $7 nlk20040147211
- 650 07
- $a farmakoterapie $2 mednas $7 nlk20040147632
- 650 07
- $a bakteriální nemoci kůže $2 czmesh $7 D017192
- 650 07
- $a ekzematózní onemocnění kůže $2 czmesh $7 D017443
- 650 07
- $a virová kožní onemocnění $2 czmesh $7 D017193
- 650 07
- $a parazitární onemocnění kůže $2 czmesh $7 D012876
- 650 07
- $a papuloskvamózní nemoci kůže $2 czmesh $7 D017444
- 650 07
- $a vezikulobulózní nemoci kůže $2 czmesh $7 D012872
- 650 07
- $a farmakoterapie $2 mednas $7 nlk20040147632
- 655 _4
- $a publikace WHO $7 nlk20040156070
- 710 2_
- $a Světová zdravotnická organizace $7 kn20010711442
- 830 _0
- $a WHO model prescribing information
- 910 __
- $a ABA008 $b K 69171 $y x
- 910 __
- $a ABE015 $b W 217 $y 1
- 990 __
- $a 19971217 $b ABA008
- 991 __
- $a 20080520094348 $b ABE015
- BAS __
- $a SKM $a 02 $a 27 $a 11 $a 49 $a MRG
- BAS __
- $a NML $a 02 $a 11 $a 49
- LZP __
- $a odf $b 17.12.1997 /321